Clostridium perfringens enterotoxin (CPE) is emerging as one of the most important bacterial virulence factors for gastrointestinal (G.I.) disease. There is compelling epidemiologic evidence for the involvement of CPE in one of the most common human food poisonings; recent studies also link CPE-positive C. perfringens to other serious human gastrointestinal illnesses and to Sudden Infant Death Syndrome. CPE has a unique action on mammalian membranes which is distinguishable from all other known toxins. Every step of CPE action involves close co-participation between CPE and mammalian membrane proteins. The long-term objective of this project is to understand the role of CPE (and CPE-positive isolates) in human disease; these studies may ultimately identify strategies to prevent or treat CPE-associated illnesses. To accomplish this objective, the following specific aims are proposed: 1) to test a recent hypothesis that a 50kDa membrane protein serves as a functional CPE receptor (the binding of CPE to the CPE receptor is essential for cytotoxicity) using """"""""anti-receptor antibody"""""""" CPE binding inhibition studies and cloning of the CPE receptor, 2) to further clarify CPE action by a) determining the topologic orientation of CPE in membranes and b) dissecting individual events in CPE action using both biochemical and ultrastructural techniques, 3) to high-resolution map CPE functional regions (and eventually combine this information with CPE structural data) to identify how the CPE molecule participates in cytotoxicity and 4) to dissect the molecular pathogenesis of CPE-positive isolates by studying the importance of CPE (and possibly other toxins) in the virulence of these isolates. These important studies are expected to i) increase the knowledge of how CPE participates in disease, ii) broaden perspectives of pathophysiologic mechanisms of intestinal diseases, iii) allow use of CPE as a defined probe of plasma membrane structure/function relationships and iv) provide a model for understanding sporulation-associated virulence factor regulation in the biomedically important genus Clostridia. These findings should have significance for numerous biomedical disciplines seeking to understand intestinal physiology under normal and disease conditions and how enteric pathogens cause G.I. disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI019844-16
Application #
2886432
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1982-07-01
Project End
2000-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
16
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Genetics
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Rood, Julian I; Adams, Vicki; Lacey, Jake et al. (2018) Expansion of the Clostridium perfringens toxin-based typing scheme. Anaerobe :
Theoret, James R; Li, Jihong; Navarro, Mauricio A et al. (2018) Native or Proteolytically Activated NanI Sialidase Enhances the Binding and Cytotoxic Activity of Clostridium perfringens Enterotoxin and Beta Toxin. Infect Immun 86:
Uzal, Francisco A; Navarro, Mauricio A; Li, Jihong et al. (2018) Comparative pathogenesis of enteric clostridial infections in humans and animals. Anaerobe :
Shrestha, Archana; Uzal, Francisco A; McClane, Bruce A (2018) Enterotoxic Clostridia: Clostridium perfringens Enteric Diseases. Microbiol Spectr 6:
Mi, Eric; Li, Jihong; McClane, Bruce A (2018) NanR Regulates Sporulation and Enterotoxin Production by Clostridium perfringens Type F Strain F4969. Infect Immun 86:
Freedman, John C; Hendricks, Matthew R; McClane, Bruce A (2017) The Potential Therapeutic Agent Mepacrine Protects Caco-2 Cells against Clostridium perfringens Enterotoxin Action. mSphere 2:
Li, Jihong; Freedman, John C; Evans, Daniel R et al. (2017) CodY Promotes Sporulation and Enterotoxin Production by Clostridium perfringens Type A Strain SM101. Infect Immun 85:
Freedman, John C; Shrestha, Archana; McClane, Bruce A (2016) Clostridium perfringens Enterotoxin: Action, Genetics, and Translational Applications. Toxins (Basel) 8:
Shrestha, Archana; Hendricks, Matthew R; Bomberger, Jennifer M et al. (2016) Bystander Host Cell Killing Effects of Clostridium perfringens Enterotoxin. MBio 7:
Shrestha, Archana; Uzal, Francisco A; McClane, Bruce A (2016) The interaction of Clostridium perfringens enterotoxin with receptor claudins. Anaerobe 41:18-26

Showing the most recent 10 out of 65 publications